ALGORAE PHARMACEUTICALS LIMITED — Director's Dealing 2023

Apr 26, 2023

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public. Introduced 30/09/01 Amended 01/01/11

Name of entity LIVING CELL TECHNOLOGIES LIMTIED

ABN 14 104 028 042

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	David Richard Hainsworth
Date of last notice	31 October 2022

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest	Indirect
Nature of indirect interest	UNION SQUARE CAPITAL PTY LTD
(including registered holder)
Note: Provide details of the circumstances giving rise to the relevantinterest.	Director & Controlling Shareholder
Date of change	24 April 2023
No. of securities held prior to change	5,000,000 Ordinary Shares
Class	Ordinary Shares
Number acquired	625,000 ordinary shares
	312,500 unlisted options
Number disposed	Nil
Value/Consideration	$5,000
Note: If consideration is non-cash, provide details and estimated valuation
No. of securities held after change	5,625,000 Ordinary Shares
	312,500 unlisted options
Nature of change	Participation in Rights Issue
Example: on-market trade, off-market trade, exercise of options, issue of
securities under dividend reinvestment plan, participation in buy-back

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

==> picture [434 x 326] intentionally omitted <==

----- Start of picture text ----- Detail of contract N/ANature of interestName of registered holder(if issued securities)Date of changeNo. and class of securities towhich interest related prior tochangeNote: Details are only required for a contract in relationto which the interest has changedInterest acquiredInterest disposedValue/ConsiderationNote: If consideration is non-cash, provide details and anestimated valuationInterest after change----- End of picture text -----

Part 3 –[+] Closed period

Were the interests in the securities or contracts No. detailed above traded during a[+] closed period where prior written clearance was required? If so, was prior written clearance provided to allow the trade to proceed during this period? If prior written clearance was provided, on what date was this provided?

• See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011